Delivery Order SPE2DB24D6044-SPE2DB25FLJKY
- Not listed
- The Defense Logistics Agency awarded a $1,089.72 delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Cipro 5% Suspension in 100ml quantities. This firm fixed-price contract, with an ultimate completion date of September 2, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The award was made through competitive procedures with no set-aside designation, and the product will be...
- The Defense Logistics Agency awarded a delivery order valued at $4,210.72 to AmerisourceBergen Drug Corp for Cipro 10% Suspension 100ML, a broad-spectrum antibiotic pharmaceutical product. The contract utilized firm fixed price pricing with no set-aside designation, indicating competitive award through an open procurement process. The delivery order is scheduled for completion by August 1, 2025, with performance to be executed at the contractor's facility in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Cipro 5% suspension in 100ml quantities, with a ceiling value of $1,332.60 under a firm fixed-price contract structure. This non-competitive delivery order was awarded on August 25, 2025, with an ultimate completion date of August 26, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this delivery supports the federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 100ml of Cipro 5% Suspension with a ceiling value of $1,227.35. The contract employs firm fixed-price pricing with no set-aside designation, indicating competitive award. The delivery order was executed on August 27, 2025, with an ultimate completion date of August 28, 2025, and performance will take place at the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,578.64 to AmerisourceBergen Drug Corp for CIPRO 5% Suspension 100ML, a ciprofloxacin-based antibiotic pharmaceutical product. This competitively awarded, firm fixed-price delivery order was issued on July 18, 2025, with an ultimate completion date of July 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a non-set-aside procurement, indicating...
- The Defense Logistics Agency awarded a delivery order valued at $1,240.05 to AmerisourceBergen Drug Corp for CIPRO 5% Suspension 100ML, a fluoroquinolone antibiotic commonly used to treat bacterial infections across military and federal healthcare systems. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 13, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a small-value transaction...
- The Defense Logistics Agency awarded a $3,103.12 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Cipro 5% Suspension in 100ml quantities. This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of July 22, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for CIPRO 5% Suspension 100ML with a ceiling value of $1,079.02. This firm fixed-price, competitively awarded delivery order was issued on July 30, 2025, with an ultimate completion date of July 31, 2025. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical, designated SPE2DX, valued at $999.99 billion through December...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,533.93 for 100ml of Cipro 5% suspension on August 25, 2025, with an ultimate completion date of August 26, 2025. This firm fixed-price contract is non-set-aside and represents a competitive award to the pharmaceutical distributor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Cipro 500 mg tablets (100-count units) valued at $1,186.55. This firm fixed-price delivery order, with an ultimate completion date of August 4, 2025, represents a non-set-aside, competitively awarded contract and reflects the agency's continued reliance on AmerisourceBergen as a critical pharmaceutical vendor for federal medical procurement. The...
- SPE2DB24D6044Indefinite Delivery Contract
- SPE2DB24D6044-SPE2DB25FLJKYDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,461.98 to AmerisourceBergen Drug Corp for Cipro 5% Suspension in 100ml quantities, with a firm fixed price contract type. The award was issued on August 28, 2025, with an ultimate completion date of August 29, 2025. This competitive award carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement supporting federal medical supply requirements. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As the prime contractor under this comprehensive global pharmaceutical support vehicle, AmerisourceBergen Drug Corp supplies a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, generic drugs, vaccines, and medical devices across multiple therapeutic domains. The parent IDC enables the company to serve the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible delivery orders like this one.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 8/28/25 |